Country selector icon United States
Important Product Safety InformationAlert: Product and Recall Notices

Advancing insulin delivery in pump therapy


+ + + + + Medtronic Extended™ infusion sets components
+ New Infusion set Capability

Simple to use and virtually painless5


With the all-in-one serter, set changes are quick and easy to do. Watch how to insert the Extended™ infusion set and reservoir.


Remove tape

1. Remove tape

Squeeze and remove safety cap

2. Squeeze and remove safety cap

Place Serter on body

3. Place Serter on body

Press the button

4. Press the button


To get the first and only infusion set designed for twice the wear, order online or by calling 1-800-646-4633 and select option 2. (Monday - Friday, 8:00 a.m. to 6:00 p.m. Central Time). Please note that the Extended™ infusion set requires a new prescription.

Frequently asked questions


Only the Extended™ reservoir is tested and cleared to keep insulin stable and safely used for up to 7 days.
If you’re using a MiniMedTM 770G, 670G, or 630G insulin pump, you can order and use the Medtronic Extended™ infusion set. Extended™ products are not compatible with MiniMedTM Paradigm systems.
Yes, a new prescription is required for the Medtronic Extended™ infusion set and Extended™ reservoir products. If you’re interested, we can request a prescription from your healthcare team on your behalf.
No, each Medtronic Extended™ infusion set has a built-in serter.
The Medtronic Extended™ infusion set is cleared for use on the abdomen, back of the arm, lower back, buttocks, and thighs. We recommend referring to the product instructions while inserting this set.
Currently, we offer a 23” tubing with either a 6mm or 9mm cannula and a 32" tubing with 9mm cannula.
No, the Extended™ reservoir is only indicated for use with the Medtronic Extended™ infusion set. Use for a maximum of 7 days, or according to the insulin labeling, whichever duration is shorter. For more details, visit this important safety information.

No, other Medtronic infusion sets are only cleared for 2-3 days. The Extended™ infusion set has new technology and different materials that allow it to be worn for twice the wear time.

The Medtronic Extended™ infusion set is designed with new materials to allow for longer wear (up to 7 days). Three updates have been made to the materials in the tubing connector, the tubing itself and the adhesive patch.
Although the insertion is the same as Mio™ Advance, as well as the look and feel, improvements have been made to the tubing, tubing connector, and adhesive patch so that it can last longer. The two sets can be visibly distinguished from one another because the Extended™ infusion set has blue packaging and blue cap.

The standard reservoir is labeled for use up to 3 days and must be changed every 3 days. We recommend using the Medtronic Extended™ infusion set and Extended™ reservoir together. The Extended™ reservoir is labeled for use up to 7 days and thus, only needs to be changed when insulin runs out or when the infusion set is changed.

Watch this video for a full tutorial.
Compare infusion sets Infusion sets support User guides and manuals Shop online

References

1. Chattaraj S, et al. The Medtronic extended-wear infusion set: Determining mechanisms of action. As presented at the 14th International Conference on Advanced Technologies & Treatments for Diabetes; June 2-5, 2021.
2. Chattaraj S, et al. Study of insulin stability impact on pump therapy: Test model development. Diabetes. 2020;69 (Supplement 1):1012-P
3. Zhang G, et al. Assessment of adhesive patches for an extended-wear infusion set. Diabetes. 2020;69 (Supplement 1):986-P
4. Chattaraj S, et al. 1167-P - CSII and Insulin: Does extending the wear duration of infusion sets save expensive insulin? 80th ADA International Conference, June 2020.
5. Medtronic Data on File. MiniMed™ Mio™ Advance US Pivotal Trials. 152 patients interviewed. 2020.

* vs the 3-days infusion set MiniMed™ Quick-set™

Important Safety Information

Medtronic Extended™ infusion set
The Extended™ Infusion Set is indicated for up to 7 days of wear for the subcutaneous infusion of insulin from an infusion pump. It is NOT indicated for intravenous (IV) infusion or the infusion of blood or blood products. Inaccurate medication delivery, infection and/or site irritation may result from improper insertion and maintenance of the infusion site. Before insertion, clean the insertion site with isopropyl alcohol. Remove the needle guard before inserting the infusion set. If using this infusion set for the first time, do the first set-up in the presence of your healthcare professional. Do not leave air in the infusion set. Prime completely. Check frequently to make sure the soft cannula remains firmly in place as you may not feel pain if it pulls out. The soft cannula must always be completely inserted to receive the full amount of medication. If the infusion site becomes inflamed, replace the set, and use a new site until the first site has healed. Replace the infusion set if the tape becomes loose, or if the soft cannula becomes fully or partially dislodged from the skin. Regularly replace the infusion set as indicated in the instructions for use, or per the insulin labeling, whichever duration is shorter. For more details, see https://www.medtronicdiabetes.com/important-safety-information.

Medtronic Extended™ reservoir
The Extended™ Reservoir is indicated for the subcutaneous infusion of insulin from compatible Medtronic insulin pumps and infusion sets. Refer to your Medtronic insulin pump user guide for a list of compatible insulins and infusion sets. The reservoir is contraindicated for the infusion of blood or blood products. Use for a maximum of 7 days, or according to the insulin labeling, whichever duration is shorter. For more details, see important safety information.

MiniMed™ 770G System With SmartGuard™ Technology
The MiniMed™ 770G system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of type 1 diabetes mellitus in persons two years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 770G System includes SmartGuard™ technology, which can be programmed to automatically adjust delivery of basal insulin based on continuous glucose monitoring (CGM) sensor glucose values (SG) and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values.

The Medtronic MiniMed™ 770G System consists of the following devices: MiniMed™ 770G Insulin Pump, the Guardian™ Link (3) Transmitter, the Guardian™ Sensor (3), one-press serter, the Accu-Chek® Guide Link blood glucose meter, and the AccuChek®Guide Test Strips. The system requires a prescription.

The Guardian™ Sensor (3) has not been evaluated and is not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. All therapy adjustments should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian™ Sensor (3).

All therapy adjustments should be based on measurements obtained using the Accu-Chek® Guide Link blood glucose meter and not on values provided by the Guardian™ Sensor (3). Always check the pump display to ensure the glucose result shown agrees with the glucose results shown on the Accu-Chek® Guide Link blood glucose meter. Do not calibrate your CGM device or calculate a bolus using a blood glucose meter result taken from an alternative site. It is not recommended to calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise.

WARNING: Do not use the SmartGuard™ Auto Mode for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in SmartGuard™ Auto Mode.

WARNING: Do not use the MiniMed™ 770G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed™ 770G system.

Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. The safety of the MiniMed™ 770G system has not been studied in pregnant women. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult https://www.medtronicdiabetes.com/important-safetyinformation#minimed-770g and the appropriate user guide at https://www.medtronicdiabetes.com/download-library